Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #211573 on Biotech Values
DewDiligence
07/25/17 6:28 PM
#212644 RE: DewDiligence #211573
…U.S. Patent No. 9,714,289, relates to the method of using COM701 for activating T cells in cancer patients... The patent is expected to expire no earlier than February 2036 in the U.S.